atrasentan has been researched along with Hypercholesterolemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Best, PJ; Bonetti, PO; Holmes, DR; Lerman, A; Lerman, LO; Rodriguez-Porcel, M | 1 |
| Best, PJ; Chade, AR; Herrmann, J; Lerman, A; Lerman, LO; Napoli, C; Rodriguez-Porcel, M; Sawamura, T; Zhu, X | 1 |
| Chade, AR; Krier, JD; Lerman, A; Lerman, LO; Textor, SC | 1 |
| Best, PJ; Hasdai, D; Holmes, DR; Lerman, A; McKenna, CJ | 1 |
4 other study(ies) available for atrasentan and Hypercholesterolemia
| Article | Year |
|---|---|
Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia.
Topics: Adenosine; Animals; Atrasentan; Body Weight; Capillary Permeability; Cholesterol, Dietary; Coronary Circulation; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Hemodynamics; Hypercholesterolemia; Lipids; Microcirculation; Protein Isoforms; Pyrrolidines; Swine | 2003 |
Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia.
Topics: Animals; Atrasentan; Body Fluids; Endothelin A Receptor Antagonists; Hemodynamics; Hypercholesterolemia; Kidney; Kidney Diseases; Oxidative Stress; Pyrrolidines; Renal Circulation; Swine | 2003 |
Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.
Topics: Animals; Atrasentan; Blood Pressure; Disease Models, Animal; Endothelin A Receptor Antagonists; Glomerular Filtration Rate; Hypercholesterolemia; Imaging, Three-Dimensional; Kidney; Microcirculation; Pyrrolidines; Receptor, Angiotensin, Type 1; Renin; Sus scrofa; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A | 2006 |
Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia.
Topics: Administration, Oral; Animals; Atrasentan; Bosentan; Coronary Vessels; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Hemodynamics; Hypercholesterolemia; Pyrrolidines; Random Allocation; Receptor, Endothelin A; Sulfonamides; Swine | 1999 |